Table 4 Gender-specific association between the mean Telomere Length and the serum phosphate level.

Models^a	Quartiles	Total		Male		Female
Models^a	Quartiles	β^b (95% CI)	P Value	β^b (95% CI)	P Value	β^b (95% CI)	P Value
Model 1	Q2 v.s. Q1 Q3 v.s. Q1 Q4 v.s. Q1	0.013 (−0.009,0.025) 0.035 (0.006, 0.041) 0.038 (0.008, 0.043)	0.345 0.009 0.005	0.01 (−0.018–0.031) 0.028 (−0.006–0.047) 0.037 (0.001–0.054)	0.601 0.125 0.045	0.013 (−0.016–0.031) 0.038 (−0.001–0.046) 0.036 (−0.002–0.044)	0.522 0.057 0.078
Model 2	Q2 v.s. Q1 Q3 v.s. Q1 Q4 v.s. Q1	0.010 (−0.010, 0.024) 0.033 (0.004, 0.040) 0.039 (0.007, 0.043)	0.442 0.015 0.006	0.010 (−0.018–0.032) 0.030 (−0.004–0.049) 0.047 (0.007–0.062)	0.577 0.102 0.015	0.009 (−0.019–0.029) 0.034 (−0.004–0.044) 0.031 (−0.006–0.042)	0.666 0.098 0.138
Model 3	Q2 v.s. Q1 Q3 v.s. Q1 Q4 v.s. Q1	0.010 (−0.011, 0.023) 0.033 (0.004, 0.040) 0.040 (0.008, 0.044)	0.473 0.015 0.005	0.010 (−0.018–0.032) 0.031 (−0.004–0.049) 0.049 (0.008–0.063)	0.582 0.098 0.011	0.008 (−0.019–0.028) 0.033 (−0.004–0.044) 0.032 (−0.005–0.043)	0.703 0.101 0.123

^aAdjusted covariates:
Model 1 = age, sex, race/ethnicity,
Model 2 = Model 1 + BMI, systolic blood pressure, serum fasting glucose, serum total cholesterol, serum albumin, ALT, total calcium, serum C-reactive protein, creatinine
Model 3 = Model 2 + history of congestive heart failure, coronary heart disease, angina/angina pectoris, heart attack, stroke, cancer/malignancy and smoking
^bβ coefficients was interpreted as change of telomere length for each increase in serum phosphate.

Quick links

Search